Skip to content
10-Q

Quarterly Report

PALOMAR MEDICAL TECHNOLOGIES INC

0000881695-12-000043

← back to feed
Filed
Nov 8, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 6, 2012 19.59M sh
Shares Diluted Q3 2012 · Sep 30, 2012 18.86M sh
Shares Diluted Q3 2012 · Sep 30, 2012 18.85M sh
Shares Diluted Q3 2012 · Sep 30, 2011 18.82M sh
Shares Diluted Q3 2012 · Sep 30, 2011 18.98M sh
Capex Q3 2012 · Sep 30, 2012 $615.39K
Capex Q3 2012 · Sep 30, 2011 $945.89K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$14.83M
Operating Cash Flow Q3 2012 · Sep 30, 2011 $6.05M
Short Term Investments Q3 2012 · Sep 30, 2012 $23.11M
Short Term Investments Q3 2012 · Dec 31, 2011 $24.74M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $61.06M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $63.08M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $84.42M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $55.1M
Stockholders Equity Q3 2012 · Sep 30, 2012 $148.41M
Stockholders Equity Q3 2012 · Dec 31, 2011 $154.64M
Current Liabilities Q3 2012 · Sep 30, 2012 $14.25M
Current Liabilities Q3 2012 · Dec 31, 2011 $19.66M
Total Liabilities Q3 2012 · Sep 30, 2012 $18.45M
Total Liabilities Q3 2012 · Dec 31, 2011 $23.42M
Current Assets Q3 2012 · Sep 30, 2012 $120.69M
Current Assets Q3 2012 · Dec 31, 2011 $119.85M
Total Assets Q3 2012 · Sep 30, 2012 $166.86M
Total Assets Q3 2012 · Dec 31, 2011 $178.06M
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.25
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.45
Eps Diluted Q3 2012 · Sep 30, 2011 $0.81
Eps Diluted Q3 2012 · Sep 30, 2011 $0.49
Eps Basic Q3 2012 · Sep 30, 2012 −$0.25
Eps Basic Q3 2012 · Sep 30, 2012 −$0.45
Eps Basic Q3 2012 · Sep 30, 2011 $0.82
Eps Basic Q3 2012 · Sep 30, 2011 $0.50
Sga Expense Q3 2012 · Sep 30, 2012 $2.78M
Sga Expense Q3 2012 · Sep 30, 2012 $8.87M
Sga Expense Q3 2012 · Sep 30, 2011 −$1.12M
Sga Expense Q3 2012 · Sep 30, 2011 $6.15M
Rd Expense Q3 2012 · Sep 30, 2012 $1.87M
Rd Expense Q3 2012 · Sep 30, 2012 $8.08M
Rd Expense Q3 2012 · Sep 30, 2011 $4.27M
Rd Expense Q3 2012 · Sep 30, 2011 $11.8M
Net Income Q3 2012 · Sep 30, 2012 −$4.67M
Net Income Q3 2012 · Sep 30, 2012 −$8.44M
Net Income restated Q3 2012 · Sep 30, 2011 $15.26M
Net Income restated Q3 2012 · Sep 30, 2011 $9.37M
Operating Income Q3 2012 · Sep 30, 2012 −$4.66M
Operating Income Q3 2012 · Sep 30, 2012 −$8.25M
Operating Income restated Q3 2012 · Sep 30, 2011 $18.52M
Operating Income restated Q3 2012 · Sep 30, 2011 $12.48M
Gross Profit Q3 2012 · Sep 30, 2012 $6.79M
Gross Profit Q3 2012 · Sep 30, 2012 $29.25M
Gross Profit Q3 2012 · Sep 30, 2011 $28.35M
Gross Profit Q3 2012 · Sep 30, 2011 $49M
Revenue Q3 2012 · Sep 30, 2012 $18.48M
Revenue Q3 2012 · Sep 30, 2012 $57.15M
Revenue Q3 2012 · Sep 30, 2011 $46.05M
Revenue Q3 2012 · Sep 30, 2011 $80.47M